Eplerenone Tablet
Product Images NDC 16571-174

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Eplerenone (NDC 16571-174). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Eplerenone-struc (Eplerenone Structure)

Eplerenone-struc (Eplerenone Structure)
Chemical structure of eplerenone, showing the molecular arrangement with multiple ring structures and functional groups including ketones, an ester, and an oxygen atom within a lactone ring.*
FDA Label Image

Figure 1 (Fig 1)

Figure 1 (Fig 1)
A line graph showing cumulative incidence percentage over 27 months since randomization comparing Eplerenone and placebo. The x-axis represents months, and the y-axis shows cumulative incidence percentage. The graph includes risk numbers at various times and statistical data with p-value, relative risk, and confidence intervals.*
FDA Label Image

Figure 2 (Fig 2)

Figure 2 (Fig 2)
A forest plot titled 'Figure 2. Hazard Ratios of All-Cause Mortality by Subgroups,' showing hazard ratios with 95% confidence intervals for multiple subgroups including age, gender, race, diabetes status, hypertension, Killip class, creatinine clearance, and baseline medication use. The x-axis represents the hazard ratio comparing Eplerenone versus placebo, with values indicating whether Eplerenone or placebo had better outcomes. Total number of events and patients are listed for each subgroup on the right.*
FDA Label Image

Fig-3 (Fig 3)

Fig-3 (Fig 3)
A scatter plot chart depicting the reduction in systolic blood pressure (SBP) in mmHg against daily doses of Eplerenone in mg/day. Data points represent three different study conditions: Study 1 QD, Study 2 QD, and Study 2 BID, showing trends in SBP reduction at varying Eplerenone doses from 0 to 200 mg/day.*
FDA Label Image

Fig-4 (Fig 4)

Fig-4 (Fig 4)
A scatter plot chart showing the relationship between Eplerenone dose (mg/day) on the x-axis and reduction in diastolic blood pressure (DBP) in mmHg on the y-axis. Data points represent results from three studies with varying dosing schedules (QD and BID).*
FDA Label Image

Bottle-label (Label 25mg 30ct)

Bottle-label (Label 25mg 30ct)
Label for Eplerenone Tablets 25 mg, oral tablets, containing 30 tablets per container. The label shows the manufacturer as Rising Pharma Holdings, Inc. It includes storage instructions, batch detail placeholder, and barcode information. The product is marked as prescription only (Rx only).*
FDA Label Image

Bottle-label (Label 50mg 30ct)

Bottle-label (Label 50mg 30ct)
Label for Eplerenone Tablets 50 mg by Rising Pharma Holdings, Inc. The oral tablet bottle label indicates a quantity of 30 tablets, prescription only. Storage instructions specify temperature control between 15° to 30°C. The label includes barcode and manufacturing location in East Brunswick, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.